Consultation process contributes to new 2019 EU novel food regulation

By Will Chu

- Last updated on GMT

©iStock
©iStock
Maqui berries, casein hydrolysate and cacao pulp juice are amongst the foods subject to a consultation process that forms part of new EU regulation designed to improve conditions when bringing new and innovative foods to the market.

The process​ falls under Article 4 of the novel food Regulation (EU) 2015/2283, which comes into force this month. It requires food business operators to verify if the food is novel or not.

 “The process is an opportunity to achieve legal certainty,”​ explained Luca Bucchini, managing director of Hylobates Consulting.

“There is a potential threat as well, for some substances and nutrition companies supplying and using them as there is no clear consultation with stakeholders during the process.”

Bucchini went on to give an example of how this threat could manifest itself arguing that a substance could be used in the marketplace by several companies on the assumption it is not novel.

“One company, with little data, asks for a novel foods consultation,”​ he explained. “Other companies do not even know about the consultation, till a negative conclusion is reached and that substance is declared novel.

“It would take a significant amount of work to overturn the decision, and there might be immediate repercussions on the market.”

Bucchini said that it was true that during the consultation, other Member States were normally consulted, but trade groups or the public were not. He added that in the extreme it might even be used against competitors.

Consultation process on novel food status

The consultation process deemed Maqui berries (fruit of the Aristotelia chilensis​ plant) as “Novel when used as or in foods. Not novel only in food supplements,”​ in a judgement that could find no evidence of the food being used for nutritional purposes.

“The claim that there is no legal basis for differentiating between its use in food supplements and its use in other foodstuffs cannot be sustained -at least since the Novel Food Regulation (EU) 2015/2283 entered into force,” ​the consultation described.

It added that even before then, it was recognised practice in all the Member States to differentiate between ‘not novel’ and ‘novel, except in food supplements’.

“Novel food status for food and food supplement is separated by law. If a substance is not novel in food supplement (i.e. was used in food supplements before 1997), it may still be novel in food (not used in other foods before 1997),” ​added Bucchini.

“In practice, Maqui can continue to be used in food supplements as it is now, but its berries cannot be used to, say, make jams, though berries are traditional in Chile.”

Other foods in the process include Casein hydrolysate containing elevated levels of the tri-peptides; L-valyl-L-prolyl-L-proline (VPP) and L-isoleucyl-L-prolyl-L-proline (IPP), deemed novel when used as or in foods.

Cacao pulp juice and nut/kernel found within the fruit of the pili nut tree (Canarium ovatum​), were also classed as novel when used as or in foods.

‘Two were found not novel’

“It is noteworthy that out of the eight applications only two were found not novel,”​ (Passiflora edulis f. edulis Sims​ and cold pressed Nigella sativa​ seed oil) said Bucchini.

“Looking at the list, it seems that most were genuine requests to achieve legal certainty, with 75% resulting in a novel food determination, it seems that a concern with a misuse of the process is warranted.

“The EC should notify the public of pending requests so that interested parties can submit evidence before a determination is made. This is important as many companies have relied on self-assessment, and the authorities may not even be aware of the data.”

Related news

Show more

Related products

show more

Fermented Soy for Natural Digestive Support

Fermented Soy for Natural Digestive Support

Lallemand Bio-Ingredients | 22-Apr-2019 | Technical / White Paper

Lallemand is running a new clinical trial for Gastro-AD® in spring 2019. Gastro-AD® is a clinically studied food supplement based on non-GMO soy fermented...

Effects of MaquiBright® on Improving Eye Dryness

Effects of MaquiBright® on Improving Eye Dryness

Anklam Extrakt GmbH | 15-Apr-2019 | Clinical Study

Within the course of a randomized, double-blind, placebo-controlled trial including 74 participants in total the effect of a polyphenol-rich maqui berry...

Breakthrough in Women's Health

Breakthrough in Women's Health

Biosearch Life | 08-Apr-2019 | Clinical Study

A new study performed on women with polycystic ovary syndrome (PCOS) and fertility problems has been published in Gynecological Endocrinology. Results...

The biomimetic approach of Indena

The biomimetic approach of Indena

Indena: the botanical ingredient of Health Food industry | 08-Apr-2019 | Technical / White Paper

In the recent years the turmeric market has become deeply crowded and "noisy". The sometimes too technical approach used by certain brands confuses...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars